BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge
Main Author: | |
---|---|
Publication Date: | 2010 |
Other Authors: | , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da FIOCRUZ (ARCA) |
Download full: | https://arca.fiocruz.br/handle/icict/7370 |
Summary: | Universidad Autónoma de Madrid. Departamento de Biología Molecular. Centro de Biología Molecular Severo Ochoa. Madrid, Spain |
id |
CRUZ_99e01592c1f1743f3bbb1b09dce7dafd |
---|---|
oai_identifier_str |
oai:arca.fiocruz.br:icict/7370 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Ramírez, LauraIborra, SalvadorCortés, JimenaBonay, PedroAlonso, CarlosBarral Netto, ManoelSoto, Manuel2014-02-27T18:59:46Z2014-02-27T18:59:46Z2010RAMÍREZ, L. et al. BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge. Journal of Biomedicine and Biotechnology, p. 1-10, 2010.1110-725110.1155/2010/181690https://arca.fiocruz.br/handle/icict/7370engHindawi Publishing CorporationBALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challengeinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidad Autónoma de Madrid. Departamento de Biología Molecular. Centro de Biología Molecular Severo Ochoa. Madrid, SpainInstituto de Salud Carlos III. Centro Nacional de Microbiología. Unidad de Inmunología Viral. Majadahonda, Madrid, SpainUniversidad Autónoma de Madrid. Departamento de Biología Molecular. Centro de Biología Molecular Severo Ochoa. Madrid, SpainUniversidad Autónoma de Madrid. Departamento de Biología Molecular. Centro de Biología Molecular Severo Ochoa. Madrid, SpainUniversidad Autónoma de Madrid. Departamento de Biología Molecular. Centro de Biología Molecular Severo Ochoa. Madrid, SpainFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, BrasilUniversidad Autónoma de Madrid. Departamento de Biología Molecular. Centro de Biología Molecular Severo Ochoa. Madrid, SpainLeishmaniasis is an increasing public health problem and effective vaccines are not currently available. We have previously demonstrated that vaccination with ribosomal proteins extracts administered in combination of CpG oligodeoxynucleotides protects susceptible BALB/c mice against primary Leishmania major infection. Here, we evaluate the long-term immunity to secondary infection conferred by this vaccine.We show that vaccinated and infected BALB/c mice were able to control a secondary Leishmania major challenge, since no inflammation and very low number of parasites were observed in the site of reinfection. In addition, although an increment in the parasite burden was observed in the draining lymph nodes of the primary site of infection we did not detected inflammatory lesions at that site. Resistance against reinfection correlated to a predominant Th1 response against parasite antigens. Thus, cell cultures established from spleens and the draining lymph node of the secondary site of infection produced high levels of parasite specific IFN-γ in the absence of IL-4 and IL-10 cytokine production. In addition, reinfected mice showed a high IgG2a/IgG1 ratio for anti-Leishmania antibodies. Our results suggest that ribosomal vaccine, which prevents pathology in a primary challenge, in combination with parasite persistence might be effective for long term maintenance of immunity.Leishmania major/imunologiaVacinas contra Leishmaniose/imunologiaLeishmaniose Cutânea/imunologiaOligodesoxirribonucleotídeos/imunologiaProteínas de Protozoários/imunologiaProteínas Ribossômicas/imunologiaAnimaisAntígenos de Protozoários/imunologiaCitocinas/imunologiaCitocinas/metabolismoModelos Animais de DoençasFemininoVacinas contra Leishmaniose/farmacologiaLeishmaniose Cutânea/prevenção & controleCamundongosCamundongos Endogâmicos BALB Cinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALRamírez L BALB-C mice....pdfRamírez L BALB-C mice....pdfapplication/pdf908126https://arca.fiocruz.br/bitstreams/47f7d369-ba00-4e68-a5dc-cc606d231ef9/download5797630a6ef48b0c7b8f8c5b7b97621fMD51trueAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://arca.fiocruz.br/bitstreams/3f1b9776-7a6a-4f02-b0d6-001390990d70/download7d48279ffeed55da8dfe2f8e81f3b81fMD52falseAnonymousREADTEXTRamírez L BALB-C mice....pdf.txtRamírez L BALB-C mice....pdf.txtExtracted texttext/plain40990https://arca.fiocruz.br/bitstreams/b1022df7-1c1d-47f4-8937-4f301992fee3/downloadb475f8d442373e5d3986ee52ec29ee23MD58falseAnonymousREADTHUMBNAILRamírez L BALB-C mice....pdf.jpgRamírez L BALB-C mice....pdf.jpgGenerated Thumbnailimage/jpeg5303https://arca.fiocruz.br/bitstreams/aeb86244-08cf-46f0-9cce-086e0f57b3ac/download41986109dc3b9c63c83beae726d4e5b9MD59falseAnonymousREADicict/73702025-07-29 19:53:46.492open.accessoai:arca.fiocruz.br:icict/7370https://arca.fiocruz.brRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352025-07-29T22:53:46Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)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 |
dc.title.none.fl_str_mv |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
title |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
spellingShingle |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge Ramírez, Laura Leishmania major/imunologia Vacinas contra Leishmaniose/imunologia Leishmaniose Cutânea/imunologia Oligodesoxirribonucleotídeos/imunologia Proteínas de Protozoários/imunologia Proteínas Ribossômicas/imunologia Animais Antígenos de Protozoários/imunologia Citocinas/imunologia Citocinas/metabolismo Modelos Animais de Doenças Feminino Vacinas contra Leishmaniose/farmacologia Leishmaniose Cutânea/prevenção & controle Camundongos Camundongos Endogâmicos BALB C |
title_short |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
title_full |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
title_fullStr |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
title_full_unstemmed |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
title_sort |
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge |
author |
Ramírez, Laura |
author_facet |
Ramírez, Laura Iborra, Salvador Cortés, Jimena Bonay, Pedro Alonso, Carlos Barral Netto, Manoel Soto, Manuel |
author_role |
author |
author2 |
Iborra, Salvador Cortés, Jimena Bonay, Pedro Alonso, Carlos Barral Netto, Manoel Soto, Manuel |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Ramírez, Laura Iborra, Salvador Cortés, Jimena Bonay, Pedro Alonso, Carlos Barral Netto, Manoel Soto, Manuel |
dc.subject.decs.none.fl_str_mv |
Leishmania major/imunologia Vacinas contra Leishmaniose/imunologia Leishmaniose Cutânea/imunologia Oligodesoxirribonucleotídeos/imunologia Proteínas de Protozoários/imunologia Proteínas Ribossômicas/imunologia Animais Antígenos de Protozoários/imunologia Citocinas/imunologia Citocinas/metabolismo Modelos Animais de Doenças Feminino Vacinas contra Leishmaniose/farmacologia Leishmaniose Cutânea/prevenção & controle Camundongos Camundongos Endogâmicos BALB C |
topic |
Leishmania major/imunologia Vacinas contra Leishmaniose/imunologia Leishmaniose Cutânea/imunologia Oligodesoxirribonucleotídeos/imunologia Proteínas de Protozoários/imunologia Proteínas Ribossômicas/imunologia Animais Antígenos de Protozoários/imunologia Citocinas/imunologia Citocinas/metabolismo Modelos Animais de Doenças Feminino Vacinas contra Leishmaniose/farmacologia Leishmaniose Cutânea/prevenção & controle Camundongos Camundongos Endogâmicos BALB C |
description |
Universidad Autónoma de Madrid. Departamento de Biología Molecular. Centro de Biología Molecular Severo Ochoa. Madrid, Spain |
publishDate |
2010 |
dc.date.issued.fl_str_mv |
2010 |
dc.date.accessioned.fl_str_mv |
2014-02-27T18:59:46Z |
dc.date.available.fl_str_mv |
2014-02-27T18:59:46Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
RAMÍREZ, L. et al. BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge. Journal of Biomedicine and Biotechnology, p. 1-10, 2010. |
dc.identifier.uri.fl_str_mv |
https://arca.fiocruz.br/handle/icict/7370 |
dc.identifier.issn.none.fl_str_mv |
1110-7251 10.1155/2010/181690 |
identifier_str_mv |
RAMÍREZ, L. et al. BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge. Journal of Biomedicine and Biotechnology, p. 1-10, 2010. 1110-7251 10.1155/2010/181690 |
url |
https://arca.fiocruz.br/handle/icict/7370 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://arca.fiocruz.br/bitstreams/47f7d369-ba00-4e68-a5dc-cc606d231ef9/download https://arca.fiocruz.br/bitstreams/3f1b9776-7a6a-4f02-b0d6-001390990d70/download https://arca.fiocruz.br/bitstreams/b1022df7-1c1d-47f4-8937-4f301992fee3/download https://arca.fiocruz.br/bitstreams/aeb86244-08cf-46f0-9cce-086e0f57b3ac/download |
bitstream.checksum.fl_str_mv |
5797630a6ef48b0c7b8f8c5b7b97621f 7d48279ffeed55da8dfe2f8e81f3b81f b475f8d442373e5d3986ee52ec29ee23 41986109dc3b9c63c83beae726d4e5b9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1839715937095254016 |